HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Donegan, W. L. Search for Related Content PubMed PubMed Citation Articles by Donegan, W. L.

CA: A Cancer Journal for Clinicians, Vol 47, Issue 1 28-51, Copyright © 1997 by American Cancer Society

ARTICLES

Tumor-related prognostic factors for breast cancer

W. L. Donegan
Department of Surgery, Sinai Samaritan Medical Center, Milwaukee, Wisconsin, USA.

Interest in prognostic factors for breast cancer has been stimulated by the success of systemic adjuvant therapy for early-stage operable disease. Patients destined for recurrence can be selected for systemic adjuvant therapy, while patients not likely to recur can be spared the morbidity of unnecessary treatment. The number of tumor-related features available for prognosis has grown impressively in recent years. The purpose of this article is to review tumor-related biologic factors and relate them to prognosis and treatment objectives.

This article has been cited by other articles:

				M. Tsujimoto, K. Nakabayashi, K. Yoshidome, T. Kaneko, T. Iwase, F. Akiyama, Y. Kato, H. Tsuda, S. Ueda, K. Sato, et al. One-step Nucleic Acid Amplification for Intraoperative Detection of Lymph Node Metastasis in Breast Cancer Patients Clin. Cancer Res., August 15, 2007; 13(16): 4807 - 4816. [Abstract] [Full Text] [PDF]

				N. S. Azad, N. Rasool, C. M. Annunziata, L. Minasian, G. Whiteley, and E. C. Kohn Proteomics in Clinical Trials and Practice: Present Uses and Future Promise Mol. Cell. Proteomics, October 1, 2006; 5(10): 1819 - 1829. [Abstract] [Full Text] [PDF]

				B. A. Miller, B. F. Hankey, and T. L. Thomas Impact of Sociodemographic Factors, Hormone Receptor Status, and Tumor Grade on Ethnic Differences in Tumor Stage and Size for Breast Cancer in US Women Am. J. Epidemiol., March 15, 2002; 155(6): 534 - 545. [Abstract] [Full Text] [PDF]

				S. J. Schnitt Traditional and Newer Pathologic Factors J Natl Cancer Inst Monographs, December 1, 2001; 2001(30): 22 - 26. [Abstract] [Full Text] [PDF]

				P. O. Chappuis, L. Kapusta, L. R. Begin, N. Wong, J.-S. Brunet, S. A. Narod, J. Slingerland, and W. D. Foulkes Germline BRCA1/2 Mutations and p27Kip1 Protein Levels Independently Predict Outcome After Breast Cancer J. Clin. Oncol., December 15, 2000; 18(24): 4045 - 4052. [Abstract] [Full Text] [PDF]

				W. H. Wolberg, W. Nick Street, and O. L. Mangasarian Importance of Nuclear Morphology in Breast Cancer Prognosis Clin. Cancer Res., November 1, 1999; 5(11): 3542 - 3548. [Abstract] [Full Text] [PDF]

				L. A. Carey, N. W. Kim, S. Goodman, J. Marks, G. Henderson, C. B. Umbricht, J. S. Dome, W. Dooley, S. R. Amshey, and S. Sukumar Telomerase Activity and Prognosis in Primary Breast Cancers J. Clin. Oncol., October 1, 1999; 17(10): 3075 - 3081. [Abstract] [Full Text] [PDF]

				C. Schairer, M. Gail, C. Byrne, P. S. Rosenberg, S. R. Sturgeon, L. A. Brinton, and R. N. Hoover Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study J Natl Cancer Inst, February 3, 1999; 91(3): 264 - 270. [Abstract] [Full Text] [PDF]